Gene expression analysis in mice with elevated glial fibrillary acidic protein and Rosenthal fibers reveals a stress response followed by glial activation and neuronal dysfunction

Human Molecular Genetics

Volumn 14, Issue 16, 2005, Pages 2443-2458

  Hagemann, Tracy L ^a   Gaeta, Stephen A ^a   Smith, Mark A ^d   Johnson, Delinda A ^c   Johnson, Jeffrey A ^a,c   Messing, Albee ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; CD11B ANTIGEN; CD68 ANTIGEN; COMPLEMENT; CYTOKINE; CYTOKINE RECEPTOR; CYTOPLASM PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTATHIONE; INTERMEDIATE FILAMENT PROTEIN; IRON; MICROTUBULE ASSOCIATED PROTEIN; NEUROTRANSMITTER; PEROXIDE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR DLX; TRANSCRIPTION FACTOR DLX5; TRANSCRIPTION FACTOR GAD1; TRANSCRIPTION FACTOR GAD2; TRANSCRIPTION FACTOR NFE212; TRANSCRIPTION FACTOR PAX6; UNCLASSIFIED DRUG; VESICULAR TRANSPORT PROTEIN;

ALEXANDER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN DISEASE; CELL ACTIVATION; CONTROLLED STUDY; DETOXIFICATION; DOWN REGULATION; FEMALE; GABAERGIC SYSTEM; GENE EXPRESSION PROFILING; GENE MUTATION; GENE OVEREXPRESSION; GLUTATHIONE METABOLISM; GRANULE CELL; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; MACROPHAGE; MICROGLIA; MOUSE; NERVE CELL DEGENERATION; NONHUMAN; OLFACTORY BULB; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; ROSENTHAL FIBER; STRESS; TRANSGENIC MOUSE; WILD TYPE;

ADOLESCENT; ALEXANDER DISEASE; ANIMALS; ASTROCYTES; CELLS, CULTURED; FEMALE; GENE EXPRESSION PROFILING; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; INCLUSION BODIES; INFANT; MALE; MICE; MICE, TRANSGENIC; NEUROGLIA; NEURONS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER;

MUS MUSCULUS;

EID: 26444621444     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddi248     Document Type: Article

References (89)

1. Brenner, M., Johnson, A.B., Boespflug-Tanguy, O., Rodriguez, D., Goldman, J.E. and Messing, A. (2001) Mutations in [i#GFAP#1i], encoding glial fibrillary acidic protein, are associated with Alexander disease. [i#Nat. Genet.#1i], [b#27#1b], 117-120.
2. Alexander, W. S. (1949) Progressive fibrinoid degeneration of fibrillary astrocytes associated with mental retardation in a hydrocephalic infant. [i#Brain#1i], [b#72#1b], 373-381.
3. Herndon, R.M., Rubinstein, L.J., Freeman, J.M. and Mathieson, G. (1970) Light and electron microscopic observations on Rosenthal fibers in Alexander's disease and in multiple sclerosis. [i#J. Neuropathol. Exp. Neurol.#1i], [b#29#1b], 524-551.
4. Iwaki, T., Iwaki, A., Tateishi, J., Sakaki, Y. and Goldman, J.E. (1993) Alpha B-crystallin and 27-kDa heat shock protein are regulated by stress conditions in the central nervous system and accumulate in Rosenthal fibers. [i#Am. J. Pathol.#1i], [b#143#1b], 487-495.
5. Messing, A. and Goldman, J.E. (2004) In Lazzarini, R.A. (ed.), [i#Myelin Biology and Disorders#1i], Elsevier, Amsterdam, Vol. [b#2#1b], pp. 851-866.
6. Li, R., Messing, A., Goldman, J.E. and Brenner, M. (2002) GFAP mutations in Alexander disease. [i#Int. J. Dev. Neurosci.#1i], [b#20#1b], 259-268.
7. Mignot, C., Boespflug-Tanguy, O., Gelot, A., Dautigny, A., Pham-Dinh, D. and Rodriguez, D. (2004) Alexander disease: Putative mechanisms of an astrocytic encephalopathy. [i#Cell. Mol. Life Sci.#1i], [b#61#1b], 369-385.
8. Yang, J.M., Nam, K., Kim, S.W., Jung, S.Y., Min, H.G., Yeo, U.C., Park, K.B., Lee, J.H., Suhr, K.B., Park, J.K. and Lee, E.S. (1999) Arginine in the beginning of the 1A rod domain of the keratin 10 gene is the hot spot for the mutation in epidermolytic hyperkeratosis. [i#J. Dermatol. Sci.#1i], [b#19#1b], 126-133.
9. Fuchs, E. and Cleveland, D.W. (1998) A structural scaffolding of intermediate filaments in health and disease. [i#Science#1i], [b#279#1b], 514-519.
10. Messing, A. and Brenner, M. (2004) In Lazzarini, R.A. (ed.), [i#Myelin Biology and Disorders#1i], Elsevier, Amsterdam, Vol. [b#2#1b], pp. 1115-1124.
11. Messing, A., Head, M.W., Galles, K., Galbreath, E.J., Goldman, J.E. and Brenner, M. (1998) Fatal encephalopathy with astrocyte inclusions in GFAP transgenic mice. [i#Am. J. Pathol.#1i], [b#152#1b], 391-398.
12. Eng, L.F. and Ghimikar, R.S. (1994) GFAP and astrogliosis. [i#Brain Pathol.#1i], [b#4#1b], 229-237.
13. Eng, L.F., Ghimikar, R.S. and Lee, Y.L. (2000) Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). [i#Neurochem. Res.#1i], [b#25#1b] 1439-1451.
14. Eddleston, M. and Mucke, L. (1993) Molecular profile of reactive astrocytes - implications for their role in neurologic disease. [i#Neuroscience#1i], [b#54#1b], 15-36.
15. Privat, A. (2003) Astrocytes as support for axonal regeneration in the central nervous system of mammals. [i#Glia#1i], [b#43#1b], 91-93.
16. Crome, L. (1953) Megaloencephaly associated with hyaline pan-neuropathy. [i#Brain#1i], [b#76#1b], 215-228.
17. Friede, R.L. (1964) Alexander's disease. [i#Arch. Neurol.#1i], [b#11#1b], 414-422.
18. Borrett, D. and Becker, L.E. (1985) Alexander's disease. A disease of astrocytes. [i#Brain#1i], [b#108#1b], 367-385.
19. Townsend, J.J., Wilson, J.F., Harris, T., Coulter, D. and Fife, R. (1985) Alexander's disease. [i#Acta Neuropathol. (Berl.)#1i], [b#67#1b], 163-166.
20. Pridmore, C.L., Baraitser, M., Harding, B., Boyd, S.G., Kendall, B. and Brett, E.M. (1993) Alexander's disease: Clues to diagnosis. [i#J. Child Neurol.#1i], [b#8#1b], 134-144.
21. Martin, P.M. and O'Callaghan, J.P. (1995) A direct comparison of GFAP immunocytochemistry and GFAP concentration in various regions of ethanol-fixed rat and mouse brain. [i#J. Neurosci. Methods#1i], [b#58#1b], 181-192.
22. Li, J. and Johnson, J.A. (2002) Time-dependent changes in ARE-driven gene expression by use of a noise-filtering process for microarray data. [i#Physiol. Genomics#1i], [b#9#1b], 137-144.
23. Venugopal, R. and Jaiswal, A.K. (1996) Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:qUinone oxidoreductase1 gene. [i#Proc. Natl Acad. Sci. USA#1i], [b#93#1b], 14960-14965.
24. Wild, A.C., Moinova, H.R. and Mulcahy, R.T. (1999) Regulation of gamma-glutamylcysteine synthetase subunit gene expression by the transcription factor Nrf2. [i#J. Biol. Chem.#1i], [b#274#1b], 33627-33636.
25. Ishii, T., Itoh, K., Takahashi, S., Sato, H., Yanagawa, T., Katoh, Y., Bannai, S. and Yamamoto, M. (2000) Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. [i#J. Biol. Chem.#1i], [b#275#1b], 16023-16029.
26. Nguyen, T., Huang, H.C. and Pickett, C.B. (2000) Transcriptional regulation of the antioxidant response element. Activation by Nrf2 and repression by MafK. [i#J. Biol. Chem.#1i], [b#275#1b], 15466-15473.
27. Chanas, S.A., Jiang, Q., McMahon, M., McWalter, G.K., McLellan, L.I., Elcombe, C.R., Henderson, C.J., Wolf, C.R., Moffat, G.J., Itoh, K., Yamamoto, M. and Hayes, J.D. (2002) Loss of the Nrf2 transcription factor causes a marked reduction in constitutive and inducible expression of the glutathione [i#S#1i]-transferase Gsta1, Gsta2, Gstm1, Gstm2, Gstm3 and Gstm4 genes in the livers of male and female mice. [i#Biochem. J.#1i], [b#365#1b],405-416.
28. Long, J.E., Garel, S., Depew, M.J., Tobet, S. and Rubenstein, J.L. (2003) DLX5 regulates development of peripheral and central components of the olfactory system. [i#J. Neurosci.#1i], [b#23#1b], 568-578.
29. Masuda, Y., Sasaki, A., Shibuya, H., Ueno, N., Ikeda, K. and Watanabe, K. (2001) Dlxin-1, a novel protein that binds Dlx5 and regulates its transcriptional function. [i#J. Biol. Chem.#1i], [b#276#1b], 5331-5338.
30. Sasaki, A., Masuda, Y., Iwai, K., Ikeda, K. and Watanabe, K. (2002) A RING finger protein Praja1 regulates Dlx5-dependent transcription through its ubiquitin ligase activity for the Dlx/Msx-interacting MAGE/ Necdin family protein, Dlxin-1. [i#J. Biol. Chem.#1i], [b#277#1b], 22541-22546.
31. Stoykova, A. and Gruss, P. (1994) Roles of Pax-genes in developing and adult brain as suggested by expression patterns. [i#J. Neurosci.#1i], [b#14#1b], 1395-1412.
32. Stenman, J., Toresson, H. and Campbell, K. (2003) Identification of two distinct progenitor populations in the lateral ganglionic eminence: implications for striatal and olfactory bulb neurogenesis. [i#J. Neurosci.#1i], [b#23#1b], 167-174.
33. Toresson, H., Parmar, M. and Campbell, K. (2000) Expression of Meis and Pbx genes and their protein products in the developing telencephalon: implications for regional differentiation. [i#Mech. Dev.#1i], [b#94#1b], 183-187.
34. Serodio, P. and Rudy, B. (1998) Differential expression of Kv4 K+ channel subunits mediating subthreshold transient K+ (A-type) currents in rat brain. [i#J. Neurophysiol.#1i], [b#79#1b], 1081-1091.
35. Nagy, J.L, Li, X.B., Rempel, J., Stelmack, G., Patel, D., Staines, W.A., Yasumura, T. and Rash, J.E. (2001) Connexin26 in adult rodent central nervous system: Demonstration at astrocytic gap junctions and colocalization with connexin30 and connexin43. [i#J. Comp. Neurol.#1i], [b#441#1b], 302-323.
36. Rash, J.E., Yasumura, T., Davidson, K.G., Furman, C.S., Dudek, F.E. and Nagy, J.I. (2001) Identification of cells expressing Cx43, Cx30, Cxr26, Cx32 and Cx36 in gap junctions of rat brain and spinal cord. [i#Cell Common. Adhes.#1i], [b#8#1b], 315-320.
37. Nagy, J.I. and Rash, J.E. (2000) Connexins and gap junctions of astrocytes and oligodendrocytes in the CNS. [i#Brain Res. Rev.#1i], [b#32#1b] 29-44.
38. Donato, R. (1999) Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type. [i#Biochim. Biophys. Acta#1i], [b#1450#1b], 191-231.
39. Filipek, A., Wojda, U. and Lesniak, W. (1995) Interaction of calcyclin and its cyanogen bromide fragments with annexin II and glyceraldehyde 3-phosphate dehydrogenase. [i#Int. J. Biochem. Cell Biol.#1i], [b#27#1b], 1123-1131.
40. Seemann, J., Weber, K. and Gerke, V. (1996) Structural requirements for annexin I-S100C complex-formation. [i#Biochem. J.#1i], [b#319#1b], 123-129.
41. Mailliard, W.S., Haigler, H.T. and Schlaepfer, D.D. (1996) Calcium-dependent binding of S100C to the N-terminal domain of annexin I. [i#J Biol. Chem.#1i], [b#271#1b], 719-725.
42. Garbuglia, M., Bianchi, R., Verzini, M., Giambanco, I. and Donato, R. (1995) Annexin II2-p11(2) (calpactin I) stimulates the assembly of GFAP in a calcium- and pH-dependent manner. [i#Biochem. Biophys. Res. Common.#1i] [b#208#1b], 901-909.
43. Snipes, G.J., Suter, U., Welcher, A.A. and Shooter, E.M. (1992) Characterization of a novel peripheral nervous system myelin protein (PMP-22/SR13). [i#J. Cell Biol.#1i], [b#117#1b], 225-238.
44. Cheng, H.L., Shy, M. and Feldman, E.L. (1999) Regulation of insulin-like growth factor-binding protein-5 expression during Schwann cell differentiation. [i#Endocrinology#1i], [b#140#1b], 4478-4485.
45. Allard, J., Barron, S., Diaz, J., Lubetzki, C., Zalc, B., Schwartz, J.C. and Sokoloff, P. (1998) A rat G protein-coupled receptor selectively expressed in myelin-forming cells. [i#Eur. J. Neurosci.#1i], [b#10#1b], 1045-1053.
46. Wu, J.I., Reed, R.B., Grabowski, P.J. and Artzt, K. (2002) Function of quaking in myelination: Regulation of alternative splicing. [i#Proc. Natl Acad. Sci. USA#1i], [b#99#1b], 4233-4238.
47. Larocque, D., Pilotte, J., Chen, T., Cloutier, F., Massie, B., Pedraza, L., Couture, R., Lasko, P., Almazan, G. and Richard, S. (2002) Nuclear retention of MBP mRNAs in the quaking viable mice. [i#Neuron#1i], [b#36#1b] 815-829.
48. Johnson, D.A., Andrews, G.K., Xu, W. and Johnson, J.A. (2002) Activation of the antioxidant responsive element in primary cortical neuronal cultures derived from transgenic reporter mice. [i#J. Neurochem.#1i], [b#81#1b], 1233-1241.
49. Prochaska, H.J. and Santamaria, A.B. (1988) Direct measurement of NAD(P)H:qUinone reductase from cells cultured in micAotiter wells: a screening assay for anticarcinogenic enzyme inducers. [i#Anal. Biochem.#1i] [b#169#1b], 328-336.
50. Connor, J.R. and Menzies, S.L. (1996) Relationship of iron to oligodendrocytes and myelination. [i#Glia#1i], [b#17#1b], 83-93.
51. Lee, J.-M., Calkins, M.J., Chan, K., Kan, Y.W. and Johnson, J.A. (2003) Identification of the NF-E2-related Factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis. [i#J. Biol. Chem.#1i], [b#278#1b], 12029-12038.
52. Castellani, R.J., Perry, G., Harris, P.L.R., Monnier, V.M., Cohen, M.L. and Smith, M.A. (1997) Advanced glycation modification of Rosenthal fibers in patients with Alexander disease. [i#Neurosci. Lett.#1i], [b#231#1b] 79-82.
53. Castellani, R.J., Perry, G., Harris, P.L.R., Cohen, M.L., Sayre, L.M., Salomon, R.G. and Smith, M.A. (1998) Advanced lipid peroxidation end-products in Alexander's disease. [i#Brain Res.#1i], [b#787#1b], 15-18.
54. Patel, B.N. and David, S. (1997) A novel glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed by mammalian astrocytes. [i#J. Biol. Chem.#1i], [b#272#1b], 20185-20190.
55. Salzer, J.L., Lovejoy, L., Linder, M.C. and Rosen, C. (1998) Ran-2, a glial lineage marker, is a GPI-anchored form of ceruloplasmin. [i#J. Neurosci. Res.#1i], [b#54#1b], 147-157.
56. Klomp, L.W. and Gitlin, J.D. (1996) Expression of the ceruloplasmin gene in the human retina and brain: Implications for a pathogenic model in aceruloplasminemia. [i#Hum. Mol. Genet.#1i], [b#5#1b], 1989-1996.
57. Attieh, Z.K., Mukhopadhyay, C.K., Seshadri, V., Tripoulas, N.A. and Fox, P.L. (1999) Ceruloplasmin ferroxidase activity stimulates cellular iron uptake by a trivalent cation-specific transport mechanism. [i#J. Biol. Chem.#1i], [b#274#1b], 1116-1123.
58. Wasserman, W.W. and Fahl, W.E. (1997) Functional antioxidant responsive elements. [i#Proc. Natl Acad. Sci. USA#1i], [b#94#1b], 5361-5366.
59. Tsuji, Y., Ayaki, H., Whitman, S.P., Morrow, C.S., Torti, S.V. and Torti, F.M. (2000) Coordinate transcriptional and translational regulation of ferritin in response to oxidative stress. [i#Mol. Cell. Biol.#1i], [b#20#1b], 5818-5827.
60. Curtis, A.R., Fey, C., Morris, C.M., Bindoff, L.A., Ince, P.G., Chinnery, P.F., Coulthard, A., Jackson, M.J., Jackson, A.P., McHale, D.P. [i#et al.#1i] (2001) Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. [i#Nat. Genet.#1i], [b#28#1b], 350-354.
61. Qian, Z.M. and Shen, X. (2001) Brain iron transport and neurodegeneration. [i#Trends Mol. Med.#1i], [b#7#1b], 103-108.
62. LaVaute, T., Smith, S., Cooperman, S., Iwai, K., Land, W., Meyron-Holtz, E., Drake, S.K., Miller, G., Abu-Asab, M., Tsokos, M. [i#et al.#1i] (2001) Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice. [i#Nat. Genet.#1i], [b#27#1b], 209-214.
63. Wang, J., Asensio, V.C. and Campbell, I.L. (2002) Cytokines and chemokines as mediators of protection and injury in the central nervous system assessed in transgenic mice. [i#Curr. Top. Microbiol. Immunol.#1i] [b#265#1b], 23-48.
64. Campbell, I.L., Abraham, C.R., Masliah, E., Kemper, P., Inglis, J.D., Oldstone, M.B. and Mucke, L. (1993) Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. [i#Proc. Natl Acad. Sci. USA#1i], [b#90#1b], 10061-10065.
65. Castelnau, P.A., Garrett, R.S., Palinski, W., Witztum, J.L., Campbell, I.L. and Powell, H.C. (1998) Abnormal iron deposition associated with lipid peroxidation in transgenic mice expressing interleukin-6 in the brain. [i#J. Neuropathol. Exp. Neurol.#1i], [b#57#1b], 268-282.
66. Campbell, I.L. (1998) Transgenic mice and cytokine actions in the brain - bridging the gap between structural and functional neuropathology. [i#Brain Res. Rev.#1i], [b#26#1b], 327-336.
67. Takemura, M., Gomi, H., Colucci-Guyon, E. and Itohara, S. (2002) Protective role of phosphorylation in turnover of glial fibrillary acidic protein in mice. [i#J. Neurosci.#1i], [b#22#1b], 6972-6979.
68. Bulfone, A., Wang, F., Hevner, R., Anderson, S., Cutforth, T., Chen, S., Meneses, J., Pedersen, R., Axel, R. and Rubenstein, J.L. (1998) An olfactory sensory map develops in the absence of normal projection neurons or GABAergic interneurons. [i#Neuron#1i], [b#21#1b], 1273-1282.
69. Carleton, A., Petreanu, L.T., Lansford, R., Alvarez-Buylla, A. and Lledo, P.M. (2003) Becoming a new neuron in the adult olfactory bulb. [i#Nat. Neurosci.#1i], [b#6#1b], 507-518.
70. Schoppa, N.E. and Westbrook, G.L. (1999) Regulation of synaptic timing in the olfactory bulb by an A-type potassium current. [i#Nat. Neurosci.#1i] [b#2#1b], 1106-1113.
71. Hevner, R.F., Shi, L., Justice, N., Hsueh, Y., Sheng, M., Smiga, S., Bulfone, A., Goffinet, A.M., Campagnoni, A.T. and Rubenstein, J.L. (2001) Tbr1 regulates differentiation of the preplate and layer 6. [i#Neuron#1i], [b#29#1b], 353-366.
72. Neuman, T., Keen, A., Zuber, M.X., Kristjansson, G.I., Gruss, P. and Nornes, H.O. (1993) Neuronal expression of regulatory helix-loop-helix factor Id2 gene in mouse. [i#Dev. Biol.#1i], [b#160#1b], 186-195.
73. Verhaagen, J., Oestreicher, A.B., Gispen, W.H. and Margolis, F.L. (1989) The expression of the growth associated protein B50/GAP43 in the olfactory system of neonatal and adult rats. [i#J. Neurosci.#1i], [b#9#1b] 683-691.
74. Lois, C. and Alvarez-Buylla, A. (1994) Long-distance neuronal migration in the adult mammalian brain. [i#Science#1i], [b#264#1b], 1145-1148.
75. Gritti, A., Bonfanti, L., Doetsch, F., Caille, I., Alvarez-Buylla, A., Lim, D.A., Galli, R., Verdugo, J.M., Herrera, D.G. and Vescovi, A.L. (2002) Multipotent neural stem cells reside into the rostral extension and olfactory bulb of adult rodents. [i#J. Neurosci.#1i], [b#22#1b], 437-445.
76. McKeon, R.J., Schreiber, R.C., Rudge, J.S. and Silver, J. (1991) Reduction of neurite outgrowth in a model of glial scarring following CNS injury is correlated with the expression of inhibitory molecules on reactive astrocytes. [i#J. Neurosci.#1i], [b#11#1b], 3398-3411.
77. Costa, S., Planchenault, T., Charriere-Bertrand, C., Mouchel, Y., Fages, C., Juliano, S., Lefrancois, T., Barlovatz-Meimon, G. and Tardy, M. (2002) Astroglial permissivity for neuritic outgrowth in neuron-astrocyte cocultures depends on regulation of laminin bioavailability. [i#Glia#1i], [b#37#1b], 105-113.
78. Rozovsky, I., Wei, M., Stone, D.J., Zanjani, H., Anderson, C.P., Morgan, T.E. and Finch, C.E. (2002) Estradiol (E2) enhances neurite outgrowth by repressing glial fibrillary acidic protein expression and reorganizing laminin. [i#Endocrinology#1i], [b#143#1b], 636-646.
79. Gomi, H., Yokoyama, T., Fujimoto, K., Ideka, T., Katoh, A., Rob, T. and Itohara, S. (1995) Mice devoid of the glial fibrillary acidic protein develop normally and are susceptible to scrapie prions. [i#Neuron#1i], [b#14#1b], 29-41.
80. Pekny, M., Levéen, P., Pekna, M., Eliasson, C., Berthold, C.-H., Westermark, B. and Betsholtz, C. (1995) Mice lacking glial fibrillary acidic protein display astrocytes devoid of intermediate filaments but develop and reproduce normally. [i#EMBO J.#1i], [b#14#1b], 1590-1598.
81. McCall, M.A., Gregg, R.G., Behringer, R.R., Brenner, M., Delaney, C.L., Galbreath, E.J., Zhang, C.L., Pearce, R.A., Chin, S.Y. and Messing, A. (1996) Targeted deletion in astrocyte intermediate filament [i#(Gfap)#1i] alters neuronal physiology. [i#Proc. Natl Acad. Sci. USA#1i], [b#93#1b], 6361-6366.
82. Liedtke, W., Edelmann, W., Bieri, P.L., Chin, F.C., Cowan, N.J., Kucherlapati, R. and Raine, C.S. (1996) GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination. [i#Neuron#1i], [b#17#1b], 607-615.
83. Watase, K. and Zoghbi, H.Y. (2003) Modelling brain diseases in mice: The challenges of design and analysis. [i#Nat. Rev. Genet.#1i], [b#4#1b], 296-307.
84. Goss, J.R., Finch, C.E. and Morgan, D.G. (1991) Age-related changes in glial fibrillary acidic protein mRNA in the mouse brain. [i#Neurobiol. Aging#1i], [b#12#1b], 165-170.
85. Nichols, N.R., Day, J.R., Laping, N.J., Johnson, S.A. and Finch, C.E. (1993) GFAP mRNA increases with age in rat and human brain. [i#Neurobiol. Aging#1i], [b#14#1b], 421-429.
86. Finch, C.E. (2002) Neurons, glia, and plasticity in normal brain aging. [i#Adv. Gerontol.#1i], [b#10#1b], 35-39.
87. Lee, C.K., Weindruch, R. and Prolla, T.A. (2000) Gene-expression profile of the ageing brain in mice. [i#Nat. Genet.#1i], [b#25#1b], 294-297.
88. Weindruch, R. and Prolla, T.A. (2002) Gene expression profile of the aging brain. [i#Arch. Neurol.#1i], [b#59#1b], 1712-1714.
89. Hill, J.M. and Switzer, R.C., III (1984) The regional distribution and cellular localization of iron in the rat brain. [i#Neuroscience#1i], [b#11#1b], 595-603.